LTH is in a sustained, powerful uptrend: the stock is up 62.60% over the trailing year and 51.82% year-to-date, massively outperforming the S&P 500's 15.53% and 11.93% respective gains, with relative strength of +47.07 over one year. At $40.52, the shares sit at roughly 70.7% of the 52-week range bounded by a $24.14 low and a $47.235 high, having pulled back from the July/August peak near $45.70 but still holding well above the spring base in the mid-$20s. This positioning signals a stock in a healthy uptrend digesting gains rather than a broken chart, though the failure to reclaim the highs leaves it vulnerable to further consolidation.

Short-term momentum has clearly decelerated and diverges from the longer-term trend: the stock is down 0.52% over the past month and 3.87% over three months, versus a 41.88% gain over six months, producing negative relative strength of -1.74 (1-month) and -6.56 (3-month) against a rising SPY. The pattern of a strong 6-month and 1-year advance paired with a flat-to-negative 3-month stretch is classic mid-trend consolidation, likely mean reversion after the sharp May-June re-rating (from ~$26 in early May to ~$41 by late June) rather than a trend reversal, especially since the pullback has been orderly and contained within a $38-$46 band since August. Volume of roughly 2.56 million shares and a short ratio of 4.31 days suggest moderate speculative positioning but no acute squeeze dynamic.

Key technical levels are well defined: support sits at the September swing low near $38.19 and, more meaningfully, the 52-week low of $24.14, while resistance is the 52-week high of $47.235 and the $45.70 July peak. A breakout above $47.24 would confirm resumption of the primary uptrend and likely open a new leg higher, whereas a decisive break below $38 would signal a deeper mean-reversion toward the $33-$35 June consolidation shelf. With a beta of 1.488, LTH is roughly 49% more volatile than the market, and a max drawdown of -16.49% over the period underscores that position sizing should account for amplified swings relative to the index.

Revenue is growing at a solid double-digit clip: the most recent quarter (Q4 2025) posted $745.10 million in revenue, up 12.33% year-over-year from $663.28 million, and the trailing four quarters totaled roughly $2.995 billion ($706.04M + $761.47M + $782.65M + $745.10M). The sequential trend shows Q1 $706.04M, Q2 $761.47M, Q3 $782.65M, and Q4 $745.10M, a seasonal pattern where Q3 is the peak quarter and Q4 steps down, but every quarter is comfortably above its prior-year counterpart ($596.72M, $667.76M, $693.23M, $663.28M), confirming durable growth rather than a one-off. Membership dues of $535.10 million dominate the segment mix, with in-center spending at $191.19 million and product/service other at $18.81 million, meaning the recurring membership base is the engine and ancillary spend is the incremental margin lever.

Profitability has inflected sharply upward: Q4 2025 net income was $123.00 million (16.5% net margin) versus just $37.16 million (5.6% margin) in Q4 2024, and full-year 2025 net income across the four reported quarters sums to roughly $373.9 million. Gross margin has been stable in the 46.9%-47.5% range across 2025 quarters (47.06% in Q3, 46.95% in Q2, 47.46% in Q1), while operating margin expanded to 17.38% in Q4 from 13.11% a year earlier, and EBITDA margin reached 35.74% in Q4 versus 23.58% in the prior-year period. The reported 47.63% gross margin and 16.07% operating margin in the valuation dataset are consistent with this trajectory, and the improvement is being driven by pricing, membership mix, and operating leverage on a largely fixed club cost base rather than one-time items.

The balance sheet is the key risk offsetting the operating story: debt-to-equity stands at 2.16x, the current ratio is a thin 0.63, and interest coverage of 7.65x is adequate but not fortress-like. Free cash flow is the pressure point, with trailing free cash flow of -$20.96 million and Q4 2025 FCF of -$64.64 million after $304.50 million of capital expenditure, though operating cash flow remains robust at $239.86 million in Q4 and $251.11 million in Q3. ROE of 11.95% and ROA of 4.17% are improving but modest given the asset-heavy model, and with cash of $232.17 million against a heavy development pipeline, the company is funding growth largely from operating cash flow plus incremental debt rather than internal surplus, which keeps execution and refinancing risk in focus.